Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TCPC
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Patrick Wolfe Chief Operating Officer | TCPC BlackRock TCP Capital Corp. | Buy | 6,850 | $3.65 | $25.0K Buy | Form 4 ↗ |
| Mar 13, 2026 | Patrick Wolfe Chief Operating Officer | TCPC BlackRock TCP Capital Corp. | Buy | 1,375 | $3.65 | $5,019 Buy | Form 4 ↗ |
| Mar 13, 2026 | Patrick Wolfe Chief Operating Officer | TCPC BlackRock TCP Capital Corp. | Buy | 700 | $3.65 | $2,555 Buy | Form 4 ↗ |
| Mar 10, 2026 | August Daniel Worrell Co-Chief Investment Officer | TCPC BlackRock TCP Capital Corp. | Buy | 40,000 | $3.75 | $150.0K Buy | Form 4 ↗ |
| Mar 6, 2026 | Erik L. Cuellar CFO | TCPC BlackRock TCP Capital Corp. | Buy | 1,750 | $3.86 | $6,755 Buy | Form 4 ↗ |
| Mar 6, 2026 | August Daniel Worrell Co-Chief Investment Officer | TCPC BlackRock TCP Capital Corp. | Buy | 40,000 | $3.89 | $155.6K Buy | Form 4 ↗ |
| Mar 6, 2026 | Jason Mehring President | TCPC BlackRock TCP Capital Corp. | Buy | 6,500 | $3.86 | $25.1K Buy | Form 4 ↗ |
| May 13, 2025 | Karen L. Leets Director | TCPC BlackRock TCP Capital Corp. | Buy | 3,300 | $7.55 | $24.9K Buy | Form 4 ↗ |
| Mar 21, 2025 | Philip M. Tseng Director and CEO, Director | TCPC BlackRock TCP Capital Corp. | Buy | 10,000 | $7.74 | $77.4K Buy | Form 4 ↗ |
| Mar 14, 2025 | Patrick Wolfe Chief Operating Officer | TCPC BlackRock TCP Capital Corp. | Buy | 6,100 | $8.12 | $49.5K Buy | Form 4 ↗ |
| Mar 12, 2025 | Jason Mehring President | TCPC BlackRock TCP Capital Corp. | Buy | 2,400 | $8.13 | $19.5K Buy | Form 4 ↗ |
| Mar 11, 2025 | August Daniel Worrell Co-Chief Investment Officer | TCPC BlackRock TCP Capital Corp. | Buy | 10,000 | $8.06 | $80.6K Buy | Form 4 ↗ |
| Nov 27, 2024 | Jason Mehring President | TCPC BlackRock TCP Capital Corp. | Buy | 4,500 | $9.30 | $41.9K Buy | Form 4 ↗ |
| Nov 26, 2024 | August Daniel Worrell Co-Chief Investment Officer | TCPC BlackRock TCP Capital Corp. | Buy | 15,000 | $9.10 | $136.5K Buy | Form 4 ↗ |
| Mar 7, 2024 | Eric John Draut Director | TCPC BlackRock TCP Capital Corp. | Buy | 1,468 | $8.31 | $12.2K Buy | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances